https://www.selleckchem.com/pr....oducts/cabotegravir-
secondary outcomes were not significantly different between the groups. In children younger than 2 years undergoing cardiopulmonary bypass surgery for congenital heart disease, the use of nitric oxide via cardiopulmonary bypass did not significantly affect the number of ventilator-free days. These findings do not support the use of nitric oxide delivered into the cardiopulmonary bypass oxygenator during heart surgery. anzctr.org.au Identifier ACTRN12617000821392. anzctr.org.au Identifier ACTRN12617000821392.Organi
Like
Comment
Share
